BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
PBX1
,
G-protein-coupled receptor binding
,
Influenza
,
Endothelial cell
,
Alcohol
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
BRD4 protein
Summary
General Info
Curated Studies
Most Correlated Studies
Prostate adenocarcinoma C4-2 cells with gene overexpression of BET proteins BRD2/BRD3/BRD4
NUT midline carcinoma cell expression after NUT knockdown or trichostatin A treatment
BRD4 knockdown in Osteosarcoma U2OS cells
Breast epithelial MCF10A cells expressing BRD4 siRNA and treated with BET inhibitor JQ1
Ewing's sarcoma Cado-ES, CHLA10, RDES, and SK-N-MC cells treated with BET inhibitor JQ1
Explore Curated Studies Results
Literature
Most Relevant Literature
Bromodomain-containing protein 4 (BRD4): a key player in inflammatory bowel disease and potential to…
Bromodomain-containing Protein 4 regulates innate inflammation via modulation of alternative splicin…
Design, synthesis, and biological evaluation of BRD4 degraders.
Dual-target inhibitors of bromodomain-containing protein 4 (BRD4) in cancer therapy: Current situati…
BRD4: New hope in the battle against glioblastoma.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Testing the Safety and Efficacy of the Addition of A New Anti-cancer Drug, ZEN003694, to Chemotherap…
Apabetalone for Pulmonary Arterial Hypertension: a Pilot Study
Testing of the Addition of a New Anti-cancer Drug, Molibresib, to Chemotherapy Treatment (Etoposide …
Phase 1 Study of SF1126 in Combination With Nivolumab in Patients With Advanced Hepatocellular Carci…
Testing the Safety and Effectiveness of Combining Two Drugs, PLX2853 and Trametinib in the Treatment…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ